on 04 Sep 2018
Last Applicant/ Owned by
82 NE 26th Street, Unit 110
Miami
FL
33137
Serial Number
87451183 filed on 16th May 2017
Registration Number
5557249 registered on 04th Sep 2018
Filing Basis
1. filed as use application
2. use application currently
Disclaimer
NO DATA
Product research and development, not including marijuana or extracts therefrom Providing health information in the field of medical marijuana and regarding the indications and effects of particular cannabinoids; providing information pertaining to the benefits of the medicinal use of cannabis to treat certain ailments Retail drug store and pharmaceutical dispensary services that not do not feat Read More
Providing health information in the field of medical marijuana and regarding the indications and effects of particular cannabinoids; providing information pertaining to the benefits of the medicinal use of cannabis to treat certain ailments
23rd Nov 2015
09th Dec 2016
Product research and development, not including marijuana or extracts therefrom
23rd Nov 2015
09th Dec 2016
Retail drug store and pharmaceutical dispensary services that not do not feature goods containing cannabinoids or cannabis
23rd Nov 2015
09th Dec 2016
Pharmaceuticals and nutraceuticals for the treatment of pain, palliative care, nausea and vomiting, wasting syndrome and loss of appetite in AIDS and cancer patients, anorexia nervosa, Multiple sclerosis, amyotrophic lateral sclerosis, spinal cord injury, epilepsy, pain, arthritides and musculoskeletal disorders, movement disorders, glaucoma, asthma, hypertension, psychiatric disorders, anxiety, depression, sleep disorders, post-traumatic stress disorder, alcohol and opioid withdrawal symptoms, schizophrenia and psychosis, Alzheimer's disease, dementia, inflammation, inflammatory skin diseases, gastrointestinal system disorders, irritable bowel syndrome, inflammatory bowel diseases, diseases of the liver, metabolic syndrome, obesity, diabetes, diseases of the pancreas, anti-neoplastic properties, and atherosclerosis; prescription synthetic narcotics for medical use; pharmaceutical preparations for the treatment of pain, palliative care, nausea and vomiting, wasting syndrome and loss of appetite in AIDS and cancer patients, anorexia nervosa, Multiple sclerosis, amyotrophic lateral sclerosis, spinal cord injury, epilepsy, pain, arthritides and musculoskeletal disorders, movement disorders, glaucoma, asthma, hypertension, psychiatric disorders, anxiety, depression, sleep disorders, post-traumatic stress disorder, alcohol and opioid withdrawal symptoms, schizophrenia and psychosis, Alzheimer's disease, dementia, inflammation, inflammatory skin diseases, gastrointestinal system disorders, irritable bowel syndrome, inflammatory bowel diseases, diseases of the liver, metabolic syndrome, obesity, diabetes, diseases of the pancreas, anti-neoplastic properties, and atherosclerosis; none of the forgoing containing marijuana or extracts therefrom
23rd Nov 2015
09th Dec 2016
No 87451183
No Service Mark
No
No
No
No
No
No
No
No
No
Status Date | Action Taken |
---|---|
04th Sep 2023 | COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED |
26th May 2021 | ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY |
04th Sep 2018 | REGISTERED-SUPPLEMENTAL REGISTER |
30th Jul 2018 | LAW OFFICE PUBLICATION REVIEW COMPLETED |
17th Jul 2018 | EXAMINERS AMENDMENT -WRITTEN |
17th Jul 2018 | EXAMINERS AMENDMENT E-MAILED |
17th Jul 2018 | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED |
17th Jul 2018 | EXAMINER'S AMENDMENT ENTERED |
17th Jul 2018 | APPROVED FOR REGISTRATION SUPPLEMENTAL REGISTER |
27th Jun 2018 | CORRESPONDENCE RECEIVED IN LAW OFFICE |